United States Rabies Vaccine Market Report 2017

October 2017 | 102 pages | ID: UC98FAEA9FAEN
QYResearch

Abstracts

In this report, the United States Rabies Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Rabies Vaccine in these regions, from 2012 to 2022 (forecast).

United States Rabies Vaccine market competition by top manufacturers/players, with Rabies Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Sanofi-Pasteur
• Chengda
• Yisheng
• Prcmise
• VACN
• Changsheng
• BCHT
• Hissen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Pre-exposure Prophylaxis
• Post-exposure Prophylaxis

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Rabies Vaccine for each application, including

• Vero Cell Rabies Vaccine
• BHK
• Chick Embryo Cell Rabies Vaccine
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Rabies Vaccine Market Report 2017

1 RABIES VACCINE OVERVIEW

1.1 Product Overview and Scope of Rabies Vaccine
1.2 Classification of Rabies Vaccine by Product Category
  1.2.1 United States Rabies Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Rabies Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Pre-exposure Prophylaxis
  1.2.4 Post-exposure Prophylaxis
1.3 United States Rabies Vaccine Market by Application/End Users
  1.3.1 United States Rabies Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Vero Cell Rabies Vaccine
  1.3.3 BHK
  1.3.4 Chick Embryo Cell Rabies Vaccine
  1.3.5 Other
1.4 United States Rabies Vaccine Market by Region
  1.4.1 United States Rabies Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Rabies Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Rabies Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Rabies Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Rabies Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Rabies Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Rabies Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Rabies Vaccine (2012-2022)
  1.5.1 United States Rabies Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Rabies Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES RABIES VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Rabies Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Rabies Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Rabies Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Rabies Vaccine Market Competitive Situation and Trends
  2.4.1 United States Rabies Vaccine Market Concentration Rate
  2.4.2 United States Rabies Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Rabies Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RABIES VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Rabies Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Rabies Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Rabies Vaccine Price by Region (2012-2017)

4 UNITED STATES RABIES VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Rabies Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Rabies Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Rabies Vaccine Price by Type (2012-2017)
4.4 United States Rabies Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RABIES VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Rabies Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Rabies Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RABIES VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rabies Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi-Pasteur
  6.2.2 Rabies Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Chengda
  6.3.2 Rabies Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Chengda Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Yisheng
  6.4.2 Rabies Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Yisheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Prcmise
  6.5.2 Rabies Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Prcmise Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 VACN
  6.6.2 Rabies Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 VACN Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Changsheng
  6.7.2 Rabies Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Changsheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 BCHT
  6.8.2 Rabies Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 BCHT Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Hissen
  6.9.2 Rabies Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Hissen Rabies Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 RABIES VACCINE MANUFACTURING COST ANALYSIS

7.1 Rabies Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rabies Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rabies Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rabies Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RABIES VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Rabies Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Rabies Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Rabies Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Rabies Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rabies Vaccine
Figure United States Rabies Vaccine Market Size (K Doses) by Type (2012-2022)
Figure United States Rabies Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Pre-exposure Prophylaxis Product Picture
Figure Post-exposure Prophylaxis Product Picture
Figure United States Rabies Vaccine Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Rabies Vaccine by Application in 2016
Figure Vero Cell Rabies Vaccine Examples
Table Key Downstream Customer in Vero Cell Rabies Vaccine
Figure BHK Examples
Table Key Downstream Customer in BHK
Figure Chick Embryo Cell Rabies Vaccine Examples
Table Key Downstream Customer in Chick Embryo Cell Rabies Vaccine
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Rabies Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Rabies Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Rabies Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Rabies Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Rabies Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Rabies Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Rabies Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rabies Vaccine Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Rabies Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rabies Vaccine Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Rabies Vaccine Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Rabies Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rabies Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Rabies Vaccine Sales Share by Players/Suppliers
Figure United States Rabies Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Rabies Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Rabies Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rabies Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Rabies Vaccine Revenue Share by Players/Suppliers
Table United States Market Rabies Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Rabies Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Rabies Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Rabies Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Rabies Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Rabies Vaccine Product Category
Table United States Rabies Vaccine Sales (K Doses) by Region (2012-2017)
Table United States Rabies Vaccine Sales Share by Region (2012-2017)
Figure United States Rabies Vaccine Sales Share by Region (2012-2017)
Figure United States Rabies Vaccine Sales Market Share by Region in 2016
Table United States Rabies Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Rabies Vaccine Revenue Share by Region (2012-2017)
Figure United States Rabies Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Rabies Vaccine Revenue Market Share by Region in 2016
Table United States Rabies Vaccine Price (USD/Dose) by Region (2012-2017)
Table United States Rabies Vaccine Sales (K Doses) by Type (2012-2017)
Table United States Rabies Vaccine Sales Share by Type (2012-2017)
Figure United States Rabies Vaccine Sales Share by Type (2012-2017)
Figure United States Rabies Vaccine Sales Market Share by Type in 2016
Table United States Rabies Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Rabies Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rabies Vaccine by Type (2012-2017)
Figure Revenue Market Share of Rabies Vaccine by Type in 2016
Table United States Rabies Vaccine Price (USD/Dose) by Types (2012-2017)
Figure United States Rabies Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Rabies Vaccine Sales (K Doses) by Application (2012-2017)
Table United States Rabies Vaccine Sales Market Share by Application (2012-2017)
Figure United States Rabies Vaccine Sales Market Share by Application (2012-2017)
Figure United States Rabies Vaccine Sales Market Share by Application in 2016
Table United States Rabies Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Rabies Vaccine Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Novartis Rabies Vaccine Sales Growth Rate (2012-2017)
Figure Novartis Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure Novartis Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi-Pasteur Rabies Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi-Pasteur Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi-Pasteur Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table Chengda Basic Information List
Table Chengda Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Chengda Rabies Vaccine Sales Growth Rate (2012-2017)
Figure Chengda Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure Chengda Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table Yisheng Basic Information List
Table Yisheng Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Yisheng Rabies Vaccine Sales Growth Rate (2012-2017)
Figure Yisheng Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure Yisheng Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table Prcmise Basic Information List
Table Prcmise Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Prcmise Rabies Vaccine Sales Growth Rate (2012-2017)
Figure Prcmise Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure Prcmise Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table VACN Basic Information List
Table VACN Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure VACN Rabies Vaccine Sales Growth Rate (2012-2017)
Figure VACN Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure VACN Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table Changsheng Basic Information List
Table Changsheng Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Changsheng Rabies Vaccine Sales Growth Rate (2012-2017)
Figure Changsheng Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure Changsheng Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table BCHT Basic Information List
Table BCHT Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure BCHT Rabies Vaccine Sales Growth Rate (2012-2017)
Figure BCHT Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure BCHT Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table Hissen Basic Information List
Table Hissen Rabies Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Hissen Rabies Vaccine Sales Growth Rate (2012-2017)
Figure Hissen Rabies Vaccine Sales Market Share in United States (2012-2017)
Figure Hissen Rabies Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rabies Vaccine
Figure Manufacturing Process Analysis of Rabies Vaccine
Figure Rabies Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Rabies Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Rabies Vaccine
Table Distributors/Traders List
Figure United States Rabies Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Rabies Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Rabies Vaccine Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Rabies Vaccine Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Rabies Vaccine Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Rabies Vaccine Sales Volume (K Doses) Forecast by Type in 2022
Table United States Rabies Vaccine Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Rabies Vaccine Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Rabies Vaccine Sales Volume (K Doses) Forecast by Application in 2022
Table United States Rabies Vaccine Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Rabies Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rabies Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rabies Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources